CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Businesses  /  Research Services

RESEARCH SERVICES

Turning clients’ ideas into meaningful innovation.

Syngene is a publicly listed subsidiary whose core capabilities include highly effective problem-solving and scientific innovation, allied to a clear commitment to safety, quality, and operating excellence. It takes an integrated approach to the disciplines of discovery, development and manufacturing of novel molecules to ensure a quality project delivery on time, every time – all with a single-minded commitment to turning clients’ ideas into meaningful innovation.

Syngene

Syngene started as India’s first Contract Research Organisation (CRO) in early 1990. Through seamless and customised services in discovery, development and manufacturing of novel molecules – both large and small – it offers clients an end-to-end solution tailored to meet their R&D requirements. In addition to strong scientific expertise and world-class infrastructure, other factors such as an experienced leadership team, track record of quality and compliance, focus on safety, robust supply chain and strong talent pool help create a vibrant ecosystem that fosters integrated innovation. Its approach enables it to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations, expediting innovation with efficiency across the continuum.

null

Through seamless and customised services in discovery, development and manufacturing of novel molecules – both large and small – it offers clients an end-to-end solution tailored to meet their R&D requirements.

null

Syngene’s business is divided into four divisions – Discovery Services, Development Services, Manufacturing Services and Dedicated R&D Centres.

Syngene’s business is divided into four divisions – Discovery Services, Development Services, Manufacturing Services and Dedicated R&D Centres. Discovery Services conducts early-stage research, from target identification to delivery of drug candidates for further development. Development Services encompasses activities from pre-clinical to clinical trials including drug substance development, drug product development and associated services to demonstrate the safety, tolerability, and efficacy of the selected drug candidate. Manufacturing Services includes manufacturing of small and large molecules, including cGMP compliant facilities for clinical supplies and registration batches as well as commercial volumes. Dedicated R&D centres offer dedicated multi-disciplinary scientific teams, support personnel and ring-fenced infrastructure as per client specifications to support their R&D requirements.

Syngene’s innovative culture is driven by the expertise of a highly qualified team of 5,000 employees and supported by state-of the-art infrastructure and market-leading technology. Syngene works with 8 of the world’s top 10 pharmaceutical companies, to find solutions to their research, development and manufacturing challenges for small and large molecules while improving productivity, speeding up time-to-market and lowering the cost of innovation. Its comprehensive services have enabled it to establish collaborations with market leaders across the sectors it caters to as well as with smaller and virtual companies, non-profit institutions, academic centres and start-ups, among others.

OUR LEGACY
SHAREHOLDER SERVICES
 LEARNING & DEVELOPMENT
SUSTAINABILITY
KEY THERAPEUTIC AREAS
Share